2002
DOI: 10.1016/s1388-2457(01)00704-0
|View full text |Cite
|
Sign up to set email alerts
|

A new clinical scale of carpal tunnel syndrome: validation of the measurement and clinical-neurophysiological assessment

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

4
94
1
10

Year Published

2004
2004
2017
2017

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 145 publications
(109 citation statements)
references
References 26 publications
4
94
1
10
Order By: Relevance
“…It may adversely affect the quality of life of the patient (sleep disruption as the symptoms -tingling, burning and pain in the first three fingers of the hand -typically present during the night, and/or loss of sensitivity and force, which may affect manual dexterity) (2). CTS incidence in the general population has been reported to be as high as 3 cases per 1000 person-years, and CTS surgery is very common as well (1 per 1000 person-years) (3,4).…”
mentioning
confidence: 99%
“…It may adversely affect the quality of life of the patient (sleep disruption as the symptoms -tingling, burning and pain in the first three fingers of the hand -typically present during the night, and/or loss of sensitivity and force, which may affect manual dexterity) (2). CTS incidence in the general population has been reported to be as high as 3 cases per 1000 person-years, and CTS surgery is very common as well (1 per 1000 person-years) (3,4).…”
mentioning
confidence: 99%
“…The clinical severity of CTS was assessed on a 6-stage scale as follows: stage 0 = no evidence suggesting the presence of CTS; stage 1 = only nocturnal paresthesias; stage 2 = diurnal paresthesias; stage 3 = sensory deficit; stage 4 = loss of strength in the muscles; and stage 5 = complete atrophy or complete plegia. 5,6 Electrophysiological abnormalities of obese patients with CTS were evaluated on a 5-stage scale as follows: stage 1 = abnormal segmental or comparative studies; stage 2 = abnormal finger/wrist sensory conduction velocities; stage 3 = abnormal finger/wrist sensory conduction velocities and abnormal distal motor latencies; stage 4 = absence of sensory response and abnormal distal motor latency; stage 5 = absence of sensory and motor responses.…”
Section: Methodsmentioning
confidence: 99%
“…8,9 Buna göre klinik bulguların evrelendirilmesinde; sadece gece parestezileri çok hafif, gece ve gündüz parestezileri hafif, duyu kaybı orta, median innervasyonlu tenar kaslarda atrofi ve/veya güçsüzlük ağır, median innervasyonlu tenar kasların paralizisi çok ağır olarak derecelendirildi. 8 EMG çalışması, ekstremite ısısı 32 ºC ve üzeri olacak şekilde sinir iletim hızının ölçümüne uygun olarak Nihon Kohden Neuropack MEB-7102K cihazı kullanılarak yapıldı.…”
Section: Gereç Ve Yöntemlerunclassified
“…Elektrofizyolojik bulguların ciddiyetinin evrelemesinde avuç içi-bilek segmentinde anormal duyu sinir iletimleri çok hafif, parmak-bilek (I-III) segmentlerinde anormal duyu sinir iletimleri hafif, parmak-bilek (I-III) segmentlerinde anormal duyu sinir iletimlerinin yanı sıra uzamış DML orta, median DAP yokluğu ve uzamış DML ağır, median BKAP ve DAP yokluğu çok ağır evre olarak değerlendirildi. 9 Her bir hastaya provokatif testlerden hem Phalen testi hem de Tinnel testi uygulandı. Siemens Magneton 1,5 Tesla MRG ile her bir olgunun aksiyal T1 ağırlıklı 2D turbo field echo, T2 ağırlıklı ve yağ baskılı proton dansite ağırlıklı görüntüleri alındı.…”
Section: Gereç Ve Yöntemlerunclassified